14:52:03 EDT Sat 12 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Healwell AI Inc
Symbol AIDX
Shares Issued 264,828,647
Close 2025-06-10 C$ 1.36
Market Cap C$ 360,166,960
Recent Sedar Documents

Healwell expands to U.S. with Orion Health

2025-06-11 11:08 ET - News Release

Dr. Alexander Dobranowski reports

HEALWELL AI LEVERAGES ORION HEALTH TO POWER ENTRY INTO US MARKET

Healwell AI Inc. is making a strategic expansion into the U.S. health care market, aligning the group's direction following its acquisition of Orion Health. This move marks a major milestone in Healwell's mission to advance preventive care through AI-driven insights and trusted health data infrastructure.

With over two decades of experience in the United States, Orion Health has built a strong foundation supporting health information exchanges (HIEs), accountable care organizations (ACOs), clinically integrated networks (CINs), payers and health systems. Its technology powers clinical data exchange across eight states, enabling thousands of clinicians to access health information for millions of patients, every day. This embedded presence will give Healwell immediate reach and credibility in one of the world's largest and most complex health care environments.

To support this strategic expansion, Healwell has established dedicated U.S. and Canadian teams, reflecting the distinct regulatory, financing and market dynamics of each region.

"Orion has had a material presence in the USA for over two decades," said Brad Porter, chief commercial officer at Healwell. "We now have a unique opportunity to accelerate value for our customers by combining Orion's trusted platform with Healwell's next-generation AI capabilities. The robust clinical validation and data lineage features differentiates these tools in the market and ultimately reduces friction with regards to clinical adoption."

Healwell's U.S. strategy will focus on the delivery of value-based care and population health initiatives through two critical capabilities: health data infrastructure and a suite of artificial-intelligence-enabled tools to be made available as a compelling offering to ACOs, CINs, HIEs, payers and health systems.

As regulatory frameworks like TEFCA (Trusted Exchange Framework and Common Agreement), along with convergence of standards toward FHIR (Fast Healthcare Interoperability Resources) reshape the national data landscape, Healwell is introducing a modular, FHIR-native repository to work alongside Orion's robust HL7-based data repository. This approach enables a TEFCA-ready, standard-aligned architecture that supports longitudinal patient records, interoperability and real-time data sharing while providing a clear upgrade path for existing HIEs and provider networks.

Complementing this foundation is Healwell's growing suite of AI tools, which will be introduced to the market, including AI-enabled clinical search, AI-enabled clinical summarization, and AI-enabled patient identification and risk stratification. These tools are designed to integrate seamlessly into existing clinical infrastructure, helping care teams surface insights faster, reduce administrative burden and improve clinical outcomes.

"The demand for clinically validated and explainable AI is growing fast," said Dr. Alexander Dobranowski, chief executive officer of Healwell. "Our ability to embed these tools into existing systems rather than replace them means we can drive impact quickly, without disrupting workflows."

To deepen its U.S. market presence, Healwell will also focus on strategic partnerships and M&A (mergers and acquisitions). Dr. Dobranowski added, "As highlighted by our track record, we will be continuing to evaluate U.S.-oriented partnerships, acquisition opportunities and organic expansion to ensure capital allocation matches the ambition of Healwell's purpose of enabling the adoption of AI-driven preventative care."

Beyond providers and public health systems, Healwell also sees growing demand from the life sciences sector, where real-world evidence (RWE) generation, decentralized clinical trial orchestration and identifying gaps in patient care are increasingly common. With established life sciences partnerships and a platform built for scalability, Healwell is well positioned to support clinical research, clinical development and outcome-based engagement in the U.S. market. Healwell's subsidiaries Pentavere and Khure Health have an established record with U.S. life sciences and health system organizations and are currently commercially active with seven of the top 10 largest pharmaceutical companies globally.

"We're seeing real traction and a path to significant growth," said James Lee, incoming chief executive officer of Healwell. "We're making excellent progress on integration and go-to-market plans, and we're seeing significant opportunities to both expand responsibly and rationalize expenses to improve operating margins. We're at the start of the curve in proving how AI can improve patient outcomes and help health care systems become more targeted with their resources. It's an exciting time for the industry."

Healwell's U.S.-oriented portfolio of capabilities will include Healwell Data as a Service, an FHIR-compliant data store and a growing suite of AI-enabled tools that support clinical search, patient clinical summarization, patient identification and patient risk stratification. These capabilities complement Orion Health's established and scaled U.S. offerings, including Amadeus Digital Care Record, Virtuoso Digital Front Door and Communicate Direct Secure Messaging, creating an integrated platform that will deliver both infrastructure and intelligence to the frontlines of care.

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practice, and ultimately help improve patient health outcomes. Healwell is executing a strategy centred around developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTCQX market under the symbol HWAIF.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.